Rochester, N.Y. — A trailblazing new study suggests a new way to effectively treat certain types of cancer. Research conducted at the Wilmot Cancer Institute shows immunotherapy to be highly effective ...

Phase I Study of Subcutaneous Rituximab Hyaluronidase Combined With CHOP Chemotherapy for the Treatment of Diffuse Large B-Cell Lymphoma in Uganda The cohort included 103 patients (63.1% female, 36.9% ...

WASHINGTON (Reuters) - Survival rates have improved in the United States for children with three common types of blood cancer since the 1990s, thanks to improved treatment, researchers in Germany said ...

Whole-brain radiotherapy was beneficial as consolidation, while temozolomide and etoposide were associated with decreased survival.

ROCHESTER, N.Y. (WROC) — A groundbreaking Hodgkin lymphoma study from the University of Rochester Medical Center showed a 92% survival rate with fewer side effects and reduced radiation therapy use.

Please provide your email address to receive an email when new articles are posted on . Pre-transplant immune checkpoint inhibitors improved survival in relapsed Hodgkin lymphoma compared with ...